Mutant Browser

Download
Protein name Generic number Position Segment Mutation FoldChange or Qual Exp Type Ligand Reference Review
agtr2_human 21 N-term G => V N/A N/A Ylisaukko-oja T et al (2004)
agtr2_human 21 N-term G => V N/A N/A Hoe KL et al (2003)
agtr2_human 1.41x41 53 TM1 I => F N/A N/A Ylisaukko-oja T et al (2004)
agtr2_human 4.64x65 182 TM4 R => A N/A N/A Hoe KL et al (2003)
agtr2_human 5.42x43 215 TM5 K => E N/A N/A Hoe KL et al (2003)
agtr2_human 5.44x45 217 TM5 I => V N/A N/A Hoe KL et al (2003)
agtr2_human 7.32x31 297 TM7 D => K N/A N/A Hoe KL et al (2003)
agtr2_human 8.49x49 324 H8 R => Q N/A N/A Hoe KL et al (2003)
agtr2_human 337 C-term I => V N/A N/A Hoe KL et al (2003)
agtr2_human 7.41x40 306 TM7 L => V N/A N/A Broer S et al (2011)
agtr2_human 32 N-term T => R N/A N/A Broer S et al (2011)
agtr2_human 27 N-term G => R N/A N/A Broer S et al (2011)
agtr2_human 3.28x28 120 TM3 F => A N/A N/A Marie J et al (2001)
agtr2_human 4.51x51 169 TM4 C => V N/A N/A Chang HK et al (2003)
agtr2_human 7.44x43 309 TM7 T => C N/A N/A Clancy SM et al (2005)
Protein name Generic number Segment Position Mutation FoldChange or Qual Exp Type Ligand Reference Review


Residue

Diagrams

ICL1 K G P K K ICL1ECL1 Y D W L F ECL1ICL2 P F L S Q R R ICL2ECL2 D V R T I E Y L G V N A C I M A F P P E ECL2ICL3 N S Y ICL3ECL3 V I N ECL3N-term M K G N S T L A T T S K N I T S G L H F G L V N I S G N N E S T L N C S Q K P S D K H L N-termC-term I T W L Q G K R E S M S C R K S S S L R E M E T F V S C-term D A I P I L Y Y I I F V I G F L V N I V V V T L F C C Q V S S I Y I F N L A V A D L L L L A T L P L W A T Y Y S Y R G P V M C K V F G S F L T L N M F A S I F F I T C M S V D R Y Q S V I Y N P W Q A S Y I V P L V W C M A C L S S L P T F Y F R K Y A Q W S A G I A L M K N I L G F I I P L I F I A T C Y F G I R K H L L K T G K N R I T R D Q V L K M A A A V V L A F I I C W L P F H V L T F L D A L A W M G S C E V I A V I D L A L P F A I L L G F T N S C V N P F L Y C F V G N R L R S P F Q Q K V F R V
Download: PNG | SVG Increased binding/potency: >5-fold, >10-fold; Reduced binding/potency: >5-fold, >10-fold; No/low effect (<5-fold); and N/A
I N V L F G I V F I I Y Y L I P I A D 1 F N L A V A D L L L L A T L P L W A T Y 2 C T I F F I S A F M N L T L F S G F V K 3 A S Y I V P L V W C M A C L S S L P T 4 Y C T A I F I L P I I F G L I N K M L A I 5 A A V V L A F I I C W L P F H V L T F L 6 F P N V C S N T F G L L I A F P L A L 7
Download: PNG | SVG




Residue Table


GPCRdb(A)
GPCRdb(A)
AT2 receptor
TM1
1x41 1.41x41 I53
TM3
3x28 3.28x28 F120
TM4
4x51 4.51x51 C169
4x65 4.64x65 R182
TM5
5x43 5.42x43 K215
5x45 5.44x45 I217
TM7
7x31 7.32x31 D297
7x40 7.41x40 L306
7x43 7.44x43 T309
H8
8x49 8.49x49 R324